MKI67 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.977400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.665200E-01
Normal-vs-Stage2
3.505600E-01
Normal-vs-Stage3
8.880800E-01
Normal-vs-Stage4
4.743600E-01
Stage1-vs-Stage2
5.191800E-01
Stage1-vs-Stage3
7.231400E-01
Stage1-vs-Stage4
5.342000E-01
Stage2-vs-Stage3
3.578800E-01
Stage2-vs-Stage4
6.374200E-01
Stage3-vs-Stage4
4.476600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.014600E-01
Normal-vs-AfricanAmerican
7.362200E-01
Normal-vs-Asian
2.571400E-01
Caucasian-vs-AfricanAmerican
4.207000E-01
Caucasian-vs-Asian
9.959400E-01
AfricanAmerican-vs-Asian
2.937200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.716200E-01
Normal-vs-Female
4.295200E-01
Male-vs-Female
7.103000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.317400E-01
Normal-vs-Age(41-60Yrs)
3.369000E-01
Normal-vs-Age(61-80Yrs)
4.455000E-01
Normal-vs-Age(81-100Yrs)
3.031200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.882000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.865800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.704800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.449800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.603800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.055200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.168400E-01
Normal-vs-Daily Drinker
4.097200E-01
Normal-vs-Weekly Drinker
3.854400E-01
Normal-vs-Occasional Drinker
3.935600E-01
Normal-vs-Social Drinker
4.663200E-01
Non Drinker-vs-Daily Drinker
9.709800E-01
Non Drinker-vs-Weekly Drinker
3.613000E-01
Non Drinker-vs-Occasional Drinker
6.523600E-01
Non Drinker-vs-Social Drinker
9.238600E-01
Daily Drinker-vs-Weekly Drinker
3.787000E-01
Daily Drinker-vs-Occasional Drinker
6.952600E-01
Daily Drinker-vs-Social Drinker
9.030400E-01
Weekly Drinker-vs-Occasional Drinker
5.273600E-01
Weekly Drinker-vs-Social Drinker
3.572200E-01
Occasional Drinker-vs-Social Drinker
6.531400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.209200E-01
Normal-vs-Grade 2
9.496800E-01
Normal-vs-Grade 3
9.025400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.350000E-04
Grade 1-vs-Grade 3
1.830500E-04
Grade 1-vs-Grade 4
7.209200E-01
Grade 2-vs-Grade 3
4.689000E-01
Grade 2-vs-Grade 4
9.496800E-01
Grade 3-vs-Grade 4
9.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.301200E-01
Normal-vs-NonDiabetic
3.915400E-01
Diabetic-vs-NonDiabetic
3.204200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.870400E-02
Normal-vs-NoPancreatitis
4.478600E-01
Pancreatitis-vs-NoPancreatitis
2.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.273200E-01
Normal-vs-N1
3.908400E-01
N0-vs-N1
6.425600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.062400E-02
Normal-vs-TP53-NonMutant
4.998000E-01
TP53-Mutant-vs-TP53-NonMutant
3.69410000000681E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
